Henry Zijlmans

2.7k citations

33 papers · 2.0k indexed · 1 hit paper · h-index 18

Immunology top 5%
- Immunotherapy and Immune Responses 6
- Immune Cell Function and Interaction 5
Oncology top 5%
- Cancer Immunotherapy and Biomarkers 5
Materials Chemistry top 10%
Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments 6
Cancer Research
Epidemiology
- Cervical Cancer and HPV Research 8
Surgery
- Colorectal and Anal Carcinomas 7
- Genital Health and Disease 3
Molecular Biology
- Advanced biosensing and bioanalysis techniques 6

Co-authors: Hans J. Tanke R. Sam Niedbala Anton K. Raap Gemma G. Kenter Frans Van De Rijke Tim Vail Li Shang J. Bonnet
Cited by: Immunology Oncology Materials Chemistry
Journals: Nature Medicine (1 paper)Nature Biotechnology (1 paper)Cancer (1 paper)
Partner nations: Netherlands Australia United States

In The Last Decade

Henry Zijlmans

32 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Henry Zijlmans

Since Specialization

Citations

This map shows the geographic impact of Henry Zijlmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Zijlmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Zijlmans more than expected).

Fields of papers citing papers by Henry Zijlmans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Zijlmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Zijlmans. The network helps show where Henry Zijlmans may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Henry Zijlmans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Henry Zijlmans Line = papers co-authored together Henry Zijlmans links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Surgical navigation for targeted retroperitoneal lymph-node removal: a randomised, controlled, phase 3 trial EClinicalMedicine ·Harald C. Groen,Esther Wit,Wouter J. Heerink,Koert F.D. Kuhlmann,Jasper Nijkamp,Ruben van Veen,Ivo G. Schoots,Sara Balduzzi,Henry Zijlmans,Pim J. van Leeuwen,H.G. Van Der Poel,Theo J. M. Ruers	2024	2
2	Primary chemoradiation versus neoadjuvant chemotherapy followed by surgery as treatment strategy for locally advanced vulvar carcinoma (VULCANize2) International Journal of Gynecological Cancer ·Frédéric Amant,Anne Fleur van Velzen,A.K.L. Reyners,Henry Zijlmans,Eva E. Schaake,Linda S. Nooij	2024	1
3	Incidence of inguinofemoral lymph node metastases at the first local recurrence of vulvar cancer: a Dutch nationwide study British Journal of Cancer ·Noortje Pleunis,Anne-Floor W. Pouwer,Maaike H.M. Oonk,Helena C. van Doorn,Ming Y. Tjiong,Jacobus van der Velden,Henry Zijlmans,Mariëtte I.E. van Poelgeest,Eleonora B. van Dorst,B.F.M. Slangen,Lia C.G. Verhoef,Johanna M.A. Pijnenborg,Joanne A. de Hullu	2023	0
4	HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trial Journal for ImmunoTherapy of Cancer ·Noor A. M. Bakker,Jossie Rotman,Marc van Beurden,Henry Zijlmans,Maartje Van Ruiten,Sanne Samuels,Bastiaan Nuijen,Jos H. Beijnen,Karin E. de Visser,John B.A.G. Haanen,Ton N. Schumacher,Tanja D. de Gruijl,Ekaterina S. Jordanova,Gemma G. Kenter,Joost H. van den Berg,Nienke E. van Trommel	2021	12
5	Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8+ T Cells and Elevated β-Catenin Activation Compared with Squamous Cell Carcinoma Clinical Cancer Research ·Jossie Rotman,A. Marijne Heeren,Awa A. Gassama,Sinéad M. Lougheed,Noëlle Pocorni,Anita G.M. Stam,Maaike C.G. Bleeker,Henry Zijlmans,Constantijne H. Mom,Gemma G. Kenter,Ekaterina S. Jordanova,Tanja D. de Gruijl	2020	21
6	PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential Frontiers in Immunology ·Jossie Rotman,Leontine A. S. den Otter,Maaike C.G. Bleeker,Sanne Samuels,A. Marijne Heeren,Margaretha G.M. Roemer,Gemma G. Kenter,Henry Zijlmans,Nienke E. van Trommel,Tanja D. de Gruijl,Ekaterina S. Jordanova	2020	68
7	Radiotherapy is not indicated in patients with vulvar squamous cell carcinoma and only one occult intracapsular groin node metastasis Gynecologic Oncology ·Jacobus van der Velden,Noortje Pleunis,Ellen Barlow,Henry Zijlmans,Joanne A. de Hullu,Neville F. Hacker,Guus Fons	2020	10
8	The best of both worlds: a hybrid approach for optimal pre- and intraoperative identification of sentinel lymph nodes European Journal of Nuclear Medicine and Molecular Imaging ·Gijs H. KleinJan,Erik van Werkhoven,Nynke S. van den Berg,Barış Karakullukçu,Henry Zijlmans,Jos A. van der Hage,Bart A. van de Wiel,Tessa Buckle,W. Martin C. Klop,Simon Horenblas,Renato A. Valdés Olmos,Henk G. van der Poel,Fijs W. B. van Leeuwen	2018	114
9	Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancersbreakdown → Nature Medicine ·Wouter Scheper,Sander Kelderman,Lorenzo F. Fanchi,Carsten Linnemann,Gavin Bendle,Marije A. J. de Rooij,Christian Hirt,Riccardo Mezzadra,Maarten Slagter,Krijn K. Dijkstra,Roelof J.C. Kluin,Pétur Snæbjörnsson,Katy Milne,Brad H. Nelson,Henry Zijlmans,Gemma G. Kenter,Emile E. Voest,John B.A.G. Haanen,Ton N. Schumacher	2018	373
10	HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia Cancer Immunology Immunotherapy ·Sanne Samuels,A. Marijne Heeren,Henry Zijlmans,Marij J.P. Welters,Joost H. van den Berg,Daisy Philips,Pia Kvistborg,Ilina Ehsan,Suzy Scholl,Bastiaan Nuijen,Ton N. Schumacher,Marc van Beurden,Ekaterina S. Jordanova,John B.A.G. Haanen,Sjoerd H. van der Burg,Gemma G. Kenter	2017	15
11	Volume-controlled versus short drainage after inguinofemoral lymphadenectomy in vulvar cancer patients: A Dutch nationwide prospective study Gynecologic Oncology ·Anne-Floor W. Pouwer,F. Hinten,Jacobus van der Velden,R.G.V. Smolders,B.F.M. Slangen,Henry Zijlmans,Joanna IntHout,Ate G.J. van der Zee,Dorry Boll,Katja N. Gaarenstroom,Henriëtte J.G. Arts,Joanne A. de Hullu	2017	11
12	Role of IL-12p40 in cervical carcinoma British Journal of Cancer ·Henry Zijlmans,Simone Punt,Gert Jan Fleuren,J. Baptist Trimbos,Gemma G. Kenter,Arko Gorter	2012	14
13	Versican expression is associated with tumor-infiltrating CD8-positive T cells and infiltration depth in cervical cancer Modern Pathology ·Arko Gorter,Henry Zijlmans,Hestia van Gent,J. Baptist Trimbos,Gert Jan Fleuren,Ekaterina S. Jordanova	2010	44
14	Endothelium specific matrilysin (MMP-7) expression in human cancers Matrix Biology ·Cornelis F.M. Sier,Lukas J.A.C. Hawinkels,Henry Zijlmans,Kim Zuidwijk,E DEJONGEMULLER,V Ferreira,Roeland Hanemaaijer,A.A. Mulder-Stapel,Gemma G. Kenter,Hein W. Verspaget	2007	15
15	Role of tumor‐derived proinflammatory cytokines GM‐CSF, TNF‐α, and IL‐12 in the migration and differentiation of antigen‐presenting cells in cervical carcinoma Cancer ·Henry Zijlmans,Gert Jan Fleuren,Hans J. Baelde,Paul H.C. Eilers,Gemma G. Kenter,Arko Gorter	2006	38
16	EMMPRIN‐induced MMP‐2 activation cascade in human cervical squamous cell carcinoma International Journal of Cancer ·Cornelis F.M. Sier,Kim Zuidwijk,Henry Zijlmans,Roeland Hanemaaijer,A.A. Mulder-Stapel,Frans A. Prins,Enno Dreef,Gemma G. Kenter,Gert Jan Fleuren,Arko Gorter	2006	49
17	The absence of CCL2 expression in cervical carcinoma is associated with increased survival and loss of heterozygosity at 17q11.2 The Journal of Pathology ·Henry Zijlmans,Gert Jan Fleuren,Hans J. Baelde,Paul H.C. Eilers,Gemma G. Kenter,Arko Gorter	2006	68
18	Up-converting phosphor reporters for nucleic acid microarrays Nature Biotechnology ·Frans Van De Rijke,Henry Zijlmans,Li Shang,Tim Vail,Anton K. Raap,R. Sam Niedbala,Hans J. Tanke	2001	402
19	Detection of Cell and Tissue Surface Antigens Using Up-Converting Phosphors: A New Reporter Technology Analytical Biochemistry ·Henry Zijlmans,J. Bonnet,Jarrett L. Burton,Keith Kardos,Timothy Vail,R. Sam Niedbala,Hans J. Tanke	1999	269
20	Microwave irradiation in label-detection for diagnostic DNA-in situ hybridization The Histochemical Journal ·W van den Brink,Henry Zijlmans,L. P. Kok,Peter G. Bolhuis,Herman Volkers,M. E. Boon,H. J. Houthoff	1990	6

About Henry Zijlmans

Henry Zijlmans is a scholar working on Obstetrics and Gynecology, Immunology and Immunology and Allergy, having authored 33 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (8 papers), Colorectal and Anal Carcinomas (7 papers), Endometrial and Cervical Cancer Treatments (6 papers), Advanced biosensing and bioanalysis techniques (6 papers), Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immune Cell Function and Interaction (5 papers) and Genital Health and Disease (3 papers). The work is most often cited by research in Immunology (528 citations), Oncology (592 citations) and Materials Chemistry (567 citations). Henry Zijlmans has collaborated with scholars based in Netherlands, Australia and United States. Frequent co-authors include Hans J. Tanke, R. Sam Niedbala, Anton K. Raap, Gemma G. Kenter, Frans Van De Rijke, Tim Vail, Li Shang, J. Bonnet, Arko Gorter and Gert Jan Fleuren. Their work appears in journals such as Nature Medicine, Nature Biotechnology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact